Journal of Infection and Public Health
Volume 1, Issue 2 , Pages 62-71 , 2008

The impact of U.S. policies to protect healthcare workers from bloodborne pathogens: The critical role of safety-engineered devices

  • Janine Jagger

      Affiliations

    • International Healthcare Worker Safety Center, Division of Infectious Diseases, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA
    • ,
  • Jane Perry

      Affiliations

    • International Healthcare Worker Safety Center, Division of Infectious Diseases, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA
    • Corresponding Author InformationCorresponding author at: International Healthcare Worker Safety Center, University of Virginia Health System, P.O. Box 800764, Charlottesville, VA 22908, USA. Tel.: +1 434 982 3763; fax: +1 434 982 0821.
    • ,
  • Ahmed Gomaa

      Affiliations

    • Division of Surveillance Hazard Evaluation and Health Studies, National Institute for Occupational Safety and Health, U.S. Centers for Disease Control and Prevention, Cincinnati, OH, USA
    • ,
  • Elayne Kornblatt Phillips

      Affiliations

    • International Healthcare Worker Safety Center, Division of Infectious Diseases, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA

Received 2 October 2008 ,Revised 16 October 2008 ,Accepted 17 October 2008.

References 

  1. Anon. Needlestick transmission of HTLV-III from a patient infected in Africa [editorial]. Lancet 1984;2:1376–77.
  2. U.S. Centers for Disease Control and Prevention . Update: human immunodeficiency virus infections in health-care workers exposed to blood of infected patients. MMWR Morb Mortal Wkly Rep. 1987;36:285–289
  3. U.S. Centers for Disease Control and Prevention . Recommendation for prevention of HIV transmission in health-care settings. MMWR. 1987;36(Suppl. 2):1–18
  4. U.S. Department of Labor and Department of Health and Human Services. Joint advisory notice: protection against occupational exposure to hepatitis B (HBV) and human immunodeficiency virus (HIV). 52 Fed Regist 41.818; October 19, 1987. Available at: http://www.cdc.gov/niosh/hcwapp5.html. Accessed 10/2/08.
  5. U.S. Department of Labor, Occupational Safety and Health Administration . Advance notice of proposed rulemaking pertaining to occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). Fed Regist. 1987;52(November 27):45438–45441
  6. U.S. Department of Labor, Occupational Safety and Health Administration . Occupational exposure to bloodborne pathogens. Final rule. Fed Regist. 1991;56(235):64004–64182
  7. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med. 1997;157:2601–2605
  8. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997;337:1485–1490
  9. U.S. Centers for Disease Control and Prevention . Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. MMWR Morb Mortal Wkly Rep. 1998;47(No. RR-7):1–34
  10. Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol. 2003;24:86–96
  11. Jagger J, De Carli G, Perry J, Puro V, Ippolito G. Occupational exposure to bloodborne pathogens: epidemiology and prevention. In:  Wenzel RP editors. Prevention and control of nosocomial infections. Lippincott Williams & Wilkins; 2003;p. 437
  12. Centers for Disease Control and Prevention. Web page: surveillance of healthcare personnel with HIV/AIDS, as of December 2002. Table: Healthcare personnel with documented and possible occupationally acquired AIDS/HIV infection, by occupation, as of December 2002. Available at: http://www.cdc.gov/ncidod/dhqp/bp_hiv_hp_with.html. Accessed 10/02/08.
  13. Jagger J, Bentley M. Disposal-related sharp-object injuries. Adv Expo Prev. 1995;1(5):p. 1–2, 6–7, 11
  14. Kelly D. Trends in U.S. patents for needlestick prevention technology. Adv Expo Prev. 1996;2(4):7–8
  15. U.S. Food and Drug Administration . Safety alert: needlestick and other risks from hypodermic needles on secondary I.V. administration sets—piggyback and intermittent I.V. April 16, 1992. Rockville, MD: Department of Health and Human Services; 1992;
  16. Jagger J, Perry J. Comparison of EPINet data for 1993 and 2001 shows marked decline in needlestick injury rates. Adv Expo Prev. 2003;6(3):25–27
  17. U.S. Food and Drug Administration (in conjuction with the National Institute for Occupational Safety and Health and the Occupational Safety and Health Administration). Glass capillary tubes: joint safety advisory about potential risks. Rockville, MD; February 1999.
  18. International Healthcare Worker Safety Center, University of Virginia. U.S. EPINet Multihospital Sharps Injury Surveillance Network. Needlestick and Sharp-Object Reports for January 1, 1994–December 31, 1998 (5 years of data; total injuries=15,389; total number of hospitals reporting injuries=76), and January 1, 2000–December 31, 2004 (5 years of data; total number of injuries=7941; total number of hospitals reporting injuries=66). Reports available upon request.
  19. Billiet LS, Parker CR, Tanley PC, Wallas CH. Needlestick injury rate reduction during phlebotomy: a comparative study of two safety devices. Lab Med. 1991;22:120–123
  20. Orenstein R, Reynolds L, Karabaic M, Lamb A, Markowitz SM, Wong ES. Do protective devices prevent needlestick injuries among health care workers?. Am J Infect Control. 1995;23:344–351
  21. O’Connor RE, Krall SP, Megargel RE, Tan LE, Bouzoukis JK. Reducing the rate of paramedic needlesticks in emergency medical services: the role of self-capping intravenous catheters. Acad Emerg Med. 1996;3:668–674
  22. Jagger J, Bentley MB. Injuries from vascular access devices: high risk and preventable. Collaborative EPINet Surveillance Group. J Intraven Nurs. 1997;20(6, Suppl.):S33–S39
  23. U.S. Centers for Disease Control and Prevention . Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures—Minneapolis, St. Paul, New York City, and San Francisco, 1993–1995. MMWR Morb Mortal Wkly Rep. 1997;46:21–23
  24. U.S. Centers for Disease Control and Prevention . Evaluation of blunt suture needles in preventing percutaneous injuries among health-care workers during gynecologic surgical procedures—New York City, March 1993–June 1994. J Am Med Assoc. 1997;277:451–452
  25. Duesman K, Ross J. Survey of accidental needlesticks in 26 facilities using Vanishpoint automated retraction syringe. J Healthcare Saf Compliance Infect Control. 1998;2:111–114
  26. Roudot-Thoraval F, Montagne O, Schaeffer A, Dubreuil-Lemaire ML, Hachard D, Durand-Zaleski I. Costs and benefits of measures to prevent needlestick injuries in a university hospital. Infect Control Hosp Epidemiol. 1999;20(9):614–617
  27. Mendelson MH, Chen LBY, Finkelstein LE, Bailey E, Kogan G. Evaluation of a safety IV catheter (Insyte Autoguard, Becton Dickinson) using the Centers for Disease Control and Prevention (CDC) National Surveillance System for Hospital Healthcare Workers database. Infect Control Hosp Epidemiol. 2000;21:111
  28. Chen LBY, Bailey E, Kogan G, Finkelstein LE, Mendelson MH. Prevention of needlestick injuries in healthcare workers: 27 month experience with a resheathable safety winged steel needle using CDC NaSH Database. Infect Control Hosp Epidemiol. 2000;21:108
  29. Perry J. California leads the way with healthcare worker safety law. Adv Expo Prev. 1998;4(1):p. 1, 4–5
  30. Perry J. The push towards safety: manufacturers respond to changes in regulatory and legislative climate. Adv Expo Prev. 2000;5(1):5–6
  31. Pugliese G, Perry J. The Needlestick Safety and Prevention Act (H.R. 5178): what does it require?. Adv Expo Prev. 2000;5(4):p. 41–42, 46
  32. U.S. Occupational Safety and Health Administration. Record summary of the request for information on occupational exposure to bloodborne pathogens due to percutaneous injury; May 20, 1999. Available at: http://www.osha.gov/html/ndlreport052099.html. Accessed 10/02/08.
  33. U.S. General Accounting Office. Occupational safety: selected cost and benefit implications of needlestick prevention devices for hospitals. Washington, DC: GAO-01-60R; November 17, 2000.
  34. U.S. Occupational Safety and Health Administration . OSHA Instruction: enforcement procedures for the occupational exposure to bloodborne pathogens. Directive number CPL2-2.44D. Washington, DC: Department of Labor; November 5, 1999;
  35. Needlestick Safety and Prevention Act of 2000. Publication No. 106-430, 114 Stat. 1901; November 6, 2000.
  36. U.S. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; needlestick and other sharps injuries; final rule. 29 CFR Part 1910. Supplementary information; Part III: Summary and explanation. Fed Regist 2001;66(12):5318–25. Available at: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=16265&p_table=FEDERAL_REGISTER. Accessed 10/02/08.
  37. U.S. Occupational Safety and Health Administration. OSHA Instruction: Enforcement procedures for the occupational exposure to bloodborne pathogens. Directive number CPL2-2.69. Washington DC: Department of Labor; November 27, 2001. Available at: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=DIRECTIVES&p_id=2570. Accessed 10/02/08.
  38. U.S. Occupational Safety and Health Administration. Standard Interpretations: 11/26/2001—response to the American Academy of Pediatrics regarding the Needlestick Safety and Prevention Act. Available at: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=INTERPRETATIONS&p_id=24003. Accessed 10/02/08.
  39. U.S. Occupational Safety and Health Administration. Standard Interpretations: 11/21/2002—safer medical devices must be selected based on employee feedback and device effectiveness, not Group Purchasing Organizations. Available at: http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=INTERPRETATIONS&p_id=24385&p_text_version=FALSE. Accessed 10/2/08.
  40. Hogan A. Gaps and successes of safety device market conversion. Mater Manag Health Care. 2005;14(11):33–34
  41. Jagger J. Estimated incremental hospital cost of safety features by device type for needles most often associated with healthcare worker HIV seroconversions [table]. In: Jagger J, Perry J, editors. Preventing occupational exposures to bloodborne pathogens: articles from Advances in Exposure Prevention, 1994–2003. Charlottesville, VA: International Healthcare Worker Safety Center; 2004. p. 192.
  42. Sohn S, Eagan J, Sepkowitz KA, Zuccotti G. Effect of implementing safety-engineered devices on percutaneous injury epidemiology. Infect Control Hosp Epidemiol. 2004;25:536–542
  43. Perry JL, Pearson RD, Jagger J. Infected healthcare workers and patient safety: a double standard. Am J Infect Control. 2006;34:314–319
  44. Perry J. Conventional sharp devices: a dying breed?. Outpatient Surg Mag. 2003;4(6):70
  45. Bureau of Labor Statistics, U.S. Department of Labor. Career guide to industries (2008–2009 edition): health care. Table 3: employment in health care by industry segment (2006 and projected change, 2006–2016). Available at: http://www.bls.gov/oco/cg/cgs035.htm. Accessed October 2, 2008.
  46. American College of Surgeons, Committee on Perioperative Care . Statement on sharps safety. Bull Am Coll Surg. 2007;92(October (10)):34–37

PII: S1876-0341(08)00029-4

doi: 10.1016/j.jiph.2008.10.002

Journal of Infection and Public Health
Volume 1, Issue 2 , Pages 62-71 , 2008

Article Tools

* Image Usage & Resolution